Pro-Dex, Inc. (NASDAQ:PDEX – Get Free Report) CEO Kirk Richard Lee Van, Jr. sold 765 shares of the business’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $59.36, for a total transaction of $45,410.40. Following the completion of the sale, the chief executive officer directly owned 79,228 shares of the company’s stock, valued at approximately $4,702,974.08. The trade was a 0.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Pro-Dex Price Performance
Shares of Pro-Dex stock traded up $3.75 during mid-day trading on Monday, reaching $66.56. 126,003 shares of the stock traded hands, compared to its average volume of 63,089. The business has a 50-day moving average of $62.51 and a 200 day moving average of $58.01. Pro-Dex, Inc. has a fifty-two week low of $23.47 and a fifty-two week high of $77.00. The company has a quick ratio of 2.45, a current ratio of 4.10 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $212.99 million, a PE ratio of 16.12 and a beta of 0.06.
Pro-Dex (NASDAQ:PDEX – Get Free Report) last announced its earnings results on Thursday, September 3rd. The medical instruments supplier reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.20. Pro-Dex had a net margin of 17.62% and a return on equity of 25.13%. The company had revenue of $20.40 million for the quarter, compared to analysts’ expectations of $19.20 million. On average, analysts predict that Pro-Dex, Inc. will post 2.78 EPS for the current year.
Hedge Funds Weigh In On Pro-Dex
Wall Street Analyst Weigh In
Several research firms have weighed in on PDEX. Weiss Ratings upgraded shares of Pro-Dex from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, September 4th. Wall Street Zen upgraded shares of Pro-Dex from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Zacks Research upgraded shares of Pro-Dex to a “hold” rating in a report on Tuesday, May 19th. Finally, Ascendiant Capital Markets upped their price target on Pro-Dex from $70.00 to $74.00 and gave the stock a “buy” rating in a research note on Friday. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $74.00.
View Our Latest Stock Report on Pro-Dex
About Pro-Dex
Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.
Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.
Recommended Stories
- Five stocks we like better than Pro-Dex
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
